Solventum Germany GmbH
DE-MF-000038373 · Germany · Kamen
Solventum Germany GmbH is registered in the European database on medical devices as a manufacturer, with 215 devices declared. It is also registered as a device establishment with the U.S. FDA.
What this manufacturer declares
| Class IIb | 52 |
|---|---|
| Class IIa | 163 |
Most frequent device types declared: Solventum™ Micropore™ Surgical Tape.
Among these devices, 83 are declared sterile, 21 implantable, 7 active.
Devices declared under this manufacturer
- Solventum™ Adaptic™
- Solventum™ Durapore ™
- Solventum™ Impregum™
- Solventum™ Kerracel™
- Solventum™ Kerralite Cool™
- Solventum™ Kerramax Care™
- Solventum™ Medipore™
- Solventum™ Micropore™
- Solventum™ Pentamix™
- Solventum™ Photac™ Fil Quick Aplicap™
- Solventum™ Protemp™
- Solventum™ RelyX™
Showing 12 of 215 declared devices.
Catalogue references include 1530P-0D, 2991P-2, 3566SP, 3569NP, 3573E, 56660.
European nomenclature codes declared: M050101, M040204, M03050202, M04010101, Q01010106, M040404.
United States market access
| FDA establishment register | Registered with FDA |
|---|---|
| Matched entry | Solventum Germany GmbH (DE) · FDA 9611385 |
| Devices in EUDAMED | 215 |
| Country of registration | Germany |
Device-level evidence
| Devices with a numeric GTIN | 215 |
|---|---|
| Found in the U.S. device database | 44 |
| Share | 20.5 % |
Canadian market access
| Health Canada licence listing | Licensed in Canada |
|---|---|
| Matched entry | SOLVENTUM GERMANY GMBH |
What it holds in Canada
| Licences on record | 15 |
|---|---|
| Currently active | 0 |
| Class 2 devices | 10 |
| Class 3 devices | 4 |
| Class 4 devices | 1 |
| First licensed | 1999-03-05 |
Licence types: Device Family (10), Device Group Family (3), Single Device (2).
Licensed under: PHOTAC-FIL QUICK APLICAP, TOOTH BONDING RESIN, RELYX TEMP NE, DURELON, TEGADERM HIGH PERFORMANCE FOAM NON-ADHESIVE DR, PROMOGRAN COLLAGEN MATRIX WITH ORC.
North American profile: Both markets. Solventum Germany GmbH is registered in both the United States and Canada.